Hologic today announced that Glenn Muir, Executive Vice President and Chief Financial Officer, will participate in the RBC Capital Markets 2006 Healthcare Conference being held December 13-14, 2006 at the Westin Times Square Hotel in New York. Mr. Muir will be part of a panel entitled: "Image is Everything", scheduled from 12:00 - 1:00 p.m. Eastern Time on December 14, 2006.

Hologic today announced the Company will host a meeting for members of the investment community who will be attending the RSNA (Radiological Society of North America ) trade show in Chicago.

Cytyc Corporation today announced that a total of eight studies evaluating performance of the NovaSure(R) System for endometrial ablation were presented at the 33rd Annual Meeting of the American Association of Gynecologic Laparoscopists (AAGL) in Las Vegas.

Cytyc Corporation today announced that twelve studies presenting data on the MammoSite(R) Radiation Therapy System (RTS) were featured at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Philadelphia.

Hologic today announced that Rob Cascella, President and Chief Operating Officer and Glenn Muir, Chief Financial Officer, will be presenting at the JP Morgan Small/Mid Cap Conference being held November 13-15, 2006 at the Four Seasons Hotel in Boston, MA.

Cytyc Corporation today announced that twenty-one scientific abstracts evaluating the performance of the ThinPrep(R) Imaging System were published in the special programs supplement of the journal Cancer Cytopathology, distributed this week at the 54th Annual Scientific Meeting of the American Society of Cytopathology (ASC) in Toronto.

Hologic today announced plans to release its fourth quarter and fiscal 2006 operating results on Wednesday, November 8, 2006 at 8:00 a.m. (eastern). In conjunction with the release, management will host a conference call on Wednesday, November 8, 2006 at 10:00 a.m. (eastern).

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer, and Glenn Muir, Chief Financial Officer, will be presenting at the C.E. Unterberg, Towbin Life Sciences Conference being held October 30 - 31, 2006 at the Palace Hotel in New York.

Cytyc Corporation today announced that the Cellient(TM) Automated Cell Block System will be introduced at the 54th Annual Scientific Meeting of the American Society of Cytopathology November 3-8, 2006, in Toronto.

Hologic today announced the Company will host a meeting for members of the investment community who will be attending the RSNA (Radiological Society of North America ) trade show in Chicago.

Hologic will again be one of the largest exhibitors at the 92nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). With a pavilion one third bigger than last year, the Hologic exhibit will cover over 13,000 sq. ft. of the Chicago McCormick Place North Hall exhibit space.

Hologic today announced that according to a new study titled "Single reading with computer-aided detection and double reading of screening mammograms in the United Kingdom National Breast Screening Program" published in the October issue of Radiology*, the performance of a radiologist using computer aided detection (CAD) was superior to that of screening mammograms which were double read.

Hologic today announced it will open the Nasdaq Stock Market tomorrow, October 3, 2006, in New York at 9:30AM ET in recognition of National Breast Cancer Awareness Month, commemorated annually on October 1.

Hologic today announced that Glenn Muir, Executive Vice President and Chief Financial Officer, will be presenting at the UBS Life Sciences Conference being held September 25-28, 2006 at the Grand Hyatt Hotel in New York, NY.

Hologic today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Think Equity Partners 4th Annual Growth Conference being held September 11-14, 2006 at the Ritz-Carlton Hotel in San Francisco, CA.

Hologic today announced that the Federal Trade Commission (FTC) gave final approval to the consent agreement settling its dispute with Hologic regarding Hologic's acquisition of the Mammotest prone bed breast biopsy system intellectual property acquired as part of the mammography intellectual property assets purchased from Fischer Imaging Corporation in September 2005.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer, and Rob Cascella, President and Chief Operating Officer, will be presenting at the Canaccord Adams Summer Seminar being held August 8-10, 2006 at the Boston Marriott Long Wharf Hotel in Boston, MA.

Hologic today announced it has completed the acquisition of Suros Surgical Systems, Inc., a leading innovator in the field of devices used for minimally invasive breast biopsy and tissue excision.

Hologic today announced it has entered into a Credit Agreement ("the Credit Agreement") with Bank of America N.A., as Administrative Agent and JP Morgan Chase Bank, National Association as Syndication Agent.

Hologic today announced plans to release its third quarter fiscal 2006 operating results on Tuesday, July 25, 2006 at 8:00 a.m. (eastern). In conjunction with the release, management will host a conference call on Tuesday, July 25, 2006 at 10:00 a.m. (eastern).

Hologic today announced that it is the first digital mammography manufacturer to receive equipment “Type Approval” for its Selenia™ digital mammography and SecurView™ systems to be used in the Flemish part of the Belgium breast screening program.

Hologic today announced it has completed the acquisition of R2 Technology, Inc., a global leader in computer aided detection (CAD).

Hologic today announced it has signed a consent agreement with the Federal Trade Commission (FTC), which would resolve Hologic's dispute with the FTC regarding Hologic's acquisition of the Mammotest prone bed breast biopsy system intellectual property acquired as part of the mammography intellectual property assets purchased from Fischer Imaging Corporation in September 2005.

Hologic today announced that has been included in the new NASDAQ Global Select Market. The NASDAQ Global Select Market has the highest initial listing standards of any exchange in the world based on financial and liquidity requirements. Prior to the change, the company had been listed on the NASDAQ National Market.

Hologic today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Jefferies Life Sciences Conference being held June 27-28, 2006 at the Mandarin Oriental Hotel in New York, NY.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer, and Glenn Muir, Chief Financial Officer, will be presenting at the NASDAQ 17th Investor Program being held June 21, 2006 at the Chancery Court Hotel in London, England.

Hologic today announced at the Pacific Growth Equities Life Sciences Growth Conference in San Francisco, CA it has updated its previously announced Selenia guidance for fiscal third quarter and fiscal year 2006.

Hologic today announced that the Company will give an investor presentation at three upcoming conferences - the Pacific Growth Equities Life Sciences Growth Conference in San Francisco, CA; the Goldman Sachs 27th Annual Global Healthcare Conference in Dana Point, CA; and the Fifth Annual Needham & Company Biotechnology and Medical Technology Conference in New York, NY.

Hologic today announced that each of it and Suros Surgical Systems, Inc. have received a request for additional information from the Federal Trade Commission ("FTC") relating to Hologic's pending acquisition of Suros, a leading innovator in the field of devices used for minimally invasive biopsy and tissue excision.

Cytyc Corporation today announced that a study published in the May-June issue of Acta Cytologica reports that implementation of the ThinPrep(R) Imaging System significantly increased detection of cervical squamous intraepithelial lesions compared to manually screened ThinPrep(R) Pap Tests.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer, and Glenn Muir, Chief Financial Officer, will be presenting at the Bank of America Health Care Conference being held May 16-18, 2006 at the Four Seasons Hotel in Las Vegas, Nevada.

Hologic today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to use information from the Hologic DiscoveryT Dual Energy X-ray Absorptiometry (DXA) system as a predictor of coronary heart disease, stroke, and other forms of cardiovascular disease.

Hologic today announced it has acquired AEG Elektrofotografie GmbH and its group of related companies ("AEG Elektrofotografie") for a purchase price of EUR 21 million subject to adjustment, plus a one-year earn-out of EUR 1.7 million.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer, and Glenn Muir, Chief Financial Officer, will be presenting at the 31st Annual Deutsche Bank Health Care Conference being held May 2-3, 2006 at the Sheraton Boston Hotel in Boston, MA.

Hologic today announced it has entered into a definitive agreement to acquire R2 Technology, Inc., a global expert in the field of computer-aided detection (CAD).

Hologic today announced it has entered into a definitive agreement to acquire Suros Surgical Systems, Inc., a leading innovator in the field of devices used for minimally invasive biopsy and tissue excision.

Cytyc Corporation, a leading women's health company, today announced that another of England's National Health Service (NHS) Strategic Health Authorities (SHA) will convert all cervical screening to the ThinPrep(R) Pap Test.

Cytyc Corporation, a leading women's health company, today announced that four studies describing a variety of clinical and cost benefits of the ThinPrep(R) Pap Test were published in the April 2006 issue of Cytopathology, the official journal of the British Society of Clinical Cytology. The studies were conducted in Canada, Scotland, Ireland, and England.

Cytyc Corporation, a leading women's health company, today announced that studies evaluating the accuracy and cost-effectiveness of the ThinPrep(R) Imaging System for cervical cancer screening were presented at the 2006 Biennial Meeting of the American Society for Colposcopy and Cervical Cancer (ASCCP) this week in Las Vegas.

Hologic today announced that Glenn Muir, Executive Vice President and Chief Financial Officer, will be presenting at the Cowen & Co. 26th Annual Health Care Conference being held March 6-9, 2006 at the Boston Marriott Copley Place in Boston, MA.

Cytyc Corporation, a leading women's health company, today announced that all laboratories performing cervical cancer screening in Ireland are adopting the ThinPrep(R) Pap Test.

Hologic today announced that Glenn Muir, Executive Vice President and Chief Financial Officer, will be presenting at the Citigroup Investment Research Global Healthcare Conference being held February 27 - March 1, 2006 at the Mayflower Hotel in Washington, DC.

Cytyc Corporation today announced that the North Carolina State Laboratory of Public Health (SLPH) is the first state public health laboratory to convert to the ThinPrep(R) Imaging System for all cervical cancer screening.

Hologic today announced that an executive of the Company has a Rule 10b5-1 trading plan which will commence in February, 2006. This plan was adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company's insider trading policy.

Hologic today announced that an executive of the Company has a Rule 10b5-1 trading plan which will commence in February, 2006. This plan was adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company's insider trading policy.

Hologic today announced that Rob Cascella, President and Chief Operating Officer, and Glenn Muir, Chief Financial Officer, will be presenting at the 24th Annual JP Morgan Healthcare Conference being held January 8-12, 2006 at the Westin St. Francis Hotel in San Francisco, CA.